Drug pricing is one of the hottest topics in the healthcare segment. Several arguments have been put forward by people, governments, healthcare companies, and other organizations in favor of and against expensive medicines. Some of the drugs are so expensive that they are nearly out of reach of the common people. However, most of the expensive drugs available in the market are taken by a relatively small patient pool and the majority of these drugs are mainly prescribed for rare genetic diseases.
Taking the case of Zolgensma, which is one of the most expensive drugs in the US costs around USD 2.1 million in the US. The cost paid by the patient is worth justif...
